


Pharmaceuticals & Biotechnology | Small Cap
Albert David Ltd, operating in the Healthcare Services sector, showcases a mixed financial performance. The company exhibits strong solvency and coverage ratios, indicating a solid financial foundation and the ability to meet its obligations. Profitability, particularly Return on Capital Employed and Return on Equity, reflects reasonable returns, although Return on Assets is low. However, liquidity, efficiency, and growth metrics reveal areas of concern. The company's financial health is further supported by stable book value and dividend payouts. While the company demonstrates strengths in certain areas, addressing the weaknesses in liquidity, efficiency, and growth will be crucial for sustained success.
Albert David Ltd, operating in the Healthcare Services sector, showcases a mixed financial performance. The company exhibits strong solvency and coverage ratios, indicating a solid financial foundation and the ability to meet its obligations. Profitability, particularly Return on Capital Employed and Return on Equity, reflects reasonable returns, although Return on Assets is low. However, liquidity, efficiency, and growth metrics reveal areas of concern. The company's financial health is further supported by stable book value and dividend payouts. While the company demonstrates strengths in certain areas, addressing the weaknesses in liquidity, efficiency, and growth will be crucial for sustained success.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-278.84
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
-279.90
P/B RATIO
1.06
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
1.25
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
0.00
EV/EBITDA RATIO
27.50
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹730.55 as on Aug 6, 2026.
The company's growth ratios indicate a mixed performance. While asset growth shows a positive trend, revenue, operating profit, EPS, and net income growth rates are low. This suggests that the company is growing its asset base, but not translating this into increased profitability. The healthcare sector is competitive, and the company needs to focus on strategies to improve its top-line and bottom-line growth.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 27.24 | 8.95 | 6.16 | -4.7 | -3.19 |
| Operating Profit Growth Rate | 115.79 | 7.32 | 6.82 | -93.62 | 66.67 |
| Earnings Per Share (EPS) Growth | 59.27 | 2.59 | 108.5 | -77.19 | -108.66 |
| Asset Growth Rate | 17.6 | 5.49 | 17.73 | 2.61 | 1.57 |
| Net Income Growth Rate | 59.09 | 2.86 | 108.33 | -77.33 | -105.88 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Kilitch Drugs (India) Ltd | 7.12 | 22.83 | Neutral | 37.00 | 9.27 | 30.00 |
| 2 | Medico Remedies Ltd | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 3 | Kopran Ltd | 6.60 | 25.82 | Neutral | 62.00 | 6.30 | 26.00 |
| 4 | SMS Lifesciences India Ltd | 6.59 | 21.63 | Undervalued | 45.00 | 58.80 | 19.00 |
| 5 | Infinium Pharmachem Ltd | 6.42 | 26.92 | Neutral | 22.00 | 6.43 | 14.00 |
| 6 | Medicamen Biotech Ltd | 5.73 | 33.43 | Neutral | 20.00 | 6.94 | 10.00 |
| 7 | Aarey Drugs & Pharmaceuticals Ltd | 5.73 | 58.43 | Neutral | 7.00 | 1.40 | 4.00 |
| 8 | Albert David Ltd | 5.63 | -279.90 | Neutral | 5.00 | -2.62 | -1.00 |
| 9 | BPL Ltd | 5.46 | -30.53 | Neutral | -4.82 | -1.69 | -8.55 |
| 10 | Zim Laboratories Ltd | 5.41 | 41.96 | Neutral | 30.00 | 1.11 | 6.00 |
| 11 | Lyka Labs Ltd | 4.77 | -26.63 | Neutral | -4.00 | -8.93 | -10.00 |
| 12 | Nectar Lifescience Ltd | 3.83 | -2.67 | Neutral | -59.00 | -2.95 | -293.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral